KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Finished Goods (2016 - 2022)

Charles River Laboratories International (CRL) has 13 years of Finished Goods data on record, last reported at $184.6 million in Q3 2022.

  • For Q3 2022, Finished Goods rose 51.28% year-over-year to $184.6 million; the TTM value through Sep 2022 reached $184.6 million, up 51.28%, while the annual FY2021 figure was $125.8 million, 4.26% up from the prior year.
  • Finished Goods reached $184.6 million in Q3 2022 per CRL's latest filing, up from $175.9 million in the prior quarter.
  • Across five years, Finished Goods topped out at $184.6 million in Q3 2022 and bottomed at $79.6 million in Q1 2018.
  • Average Finished Goods over 5 years is $114.6 million, with a median of $107.1 million recorded in 2020.
  • Peak YoY movement for Finished Goods: increased 4.26% in 2021, then skyrocketed 51.28% in 2022.
  • A 5-year view of Finished Goods shows it stood at $83.8 million in 2018, then increased by 19.59% to $100.2 million in 2019, then rose by 20.39% to $120.6 million in 2020, then grew by 4.26% to $125.8 million in 2021, then soared by 46.76% to $184.6 million in 2022.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $184.6 million in Q3 2022, $175.9 million in Q2 2022, and $150.8 million in Q1 2022.